SEC FORM
3
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
| C/O OAK HILL CAPITAL |
| 2775 SAND HILL ROAD, #220 |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
08/01/2007
|
3. Issuer Name and Ticker or Trading Symbol
Genpact LTD
[ [G] ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Stock Option (Right to Buy) |
|
09/28/2015 |
Common Shares |
81,405 |
3.44 |
D |
|
| Explanation of Responses: |
|
|
/s/ A. Michael Spence |
08/01/2007 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
EXHIBIT 24.1
------------
POWER OF ATTORNEY
I appoint John R. Monsky, Douglas Kaden and Chandler B. Evans, together and
separately, to be my attorneys-in-fact. This means they may, in my place:
o sign Securities and Exchange Commission Forms 3, 4 and 5, and all
amendments to these forms, reporting transactions in Genpact's
securities;
o file these forms and amendments with the SEC;
o perform the acts that need to be done concerning these filings; and
o name others to take their place.
I am responsible for everything my attorneys-in-fact do when acting lawfully
within the scope of this Power of Attorney.
The attorneys-in-fact, in acting at my request, are not assuming any of my
responsibilities to comply with Section 16 of the Securities Exchange Act of
1934. Genpact is not assuming my Section 16 responsibilities either.
This Power of Attorney remains in effect until:
o I am no longer required to file Forms 3, 4 and 5 for Genpact's
securities; or
o I revoke it, in writing, and deliver the revocation to my
attorneys-in-fact.
I hereby revoke all previous Powers of Attorney that have been granted by me in
connection with my reporting obligations under Section 16 of the Securities
Exchange Act of 1934 with respect to my holdings of and transactions in
securities issued by Genpact.
/s/ A. Michael Spence
-------------------------
A. Michael Spence
Dated: July 30, 2007
